Literature DB >> 3031846

Studies on the mechanism of carbon monoxide-induced vasodilation in the isolated perfused rat heart.

S J McFaul, J J McGrath.   

Abstract

We investigated the effects of dissolved CO on isolated potassium-arrested (K+) perfused rat hearts. Hearts from male Sprague-Dawley rats were perfused via the aorta with oxygenated Krebs-Henseleit solution containing 20 mM K+. Coronary flow (Qt) averaged 48.8 +/- 1.6 (SE), 48.1 +/- 1.7, and 55.6 +/- 1.7 ml/min/g dry wt when the perfusate was equilibrated with 95% O2-5% CO2, 5% N2-90% O2-5% CO2, and 5% CO-90% O2-5% CO2, respectively. The change in Qt was statistically significant when CO was present in the perfusion medium, but was not significant when N2 was present. Furthermore, the effect was reversible because coronary flow returned to control levels when CO was removed. Myocardial oxygen consumption (MVO2) did not change significantly when hearts were perfused with either N2 or CO. The magnitude of CO-induced vasodilation was not affected significantly by the addition of either 5 microM propranolol, 2 microM phentolamine, 1 unit of adenosine deaminase, or 0.1 mM indomethacin to the perfusate. In addition, CO reversed the vasoconstrictive effects of the alpha-agonist methoxamine. These results indicate that CO exerts a vasodilatory effect on coronary vasculature that is not the result of decreased O2 content in the perfusate and is not mediated by adrenergic influences, adenosine, or prostaglandins.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3031846     DOI: 10.1016/0041-008x(87)90252-3

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  10 in total

1.  Exercising skeletal muscle blood flow in humans responds to reduction in arterial oxyhaemoglobin, but not to altered free oxygen.

Authors:  J Gonzalez-Alonso; R S Richardson; B Saltin
Journal:  J Physiol       Date:  2001-01-15       Impact factor: 5.182

Review 2.  Gasotransmitters in pregnancy: from conception to uterine involution.

Authors:  Damian D Guerra; K Joseph Hurt
Journal:  Biol Reprod       Date:  2019-07-01       Impact factor: 4.285

Review 3.  [Carbon monoxide--poison or potential therapeutic?].

Authors:  A Hoetzel; R Schmidt
Journal:  Anaesthesist       Date:  2006-10       Impact factor: 1.041

4.  Haeme oxygenase-1 and cardiac anaphylaxis.

Authors:  J F Ndisang; R Wang; A Vannacci; C Marzocca; O Fantappiè; R Mazzanti; P F Mannaioni; E Masini
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

Review 5.  Mitochondria and carbon monoxide: cytoprotection and control of cell metabolism - a role for Ca(2+) ?

Authors:  Sara R Oliveira; Cláudia S F Queiroga; Helena L A Vieira
Journal:  J Physiol       Date:  2015-12-07       Impact factor: 5.182

6.  Hemoxygenase and nitric oxide synthase do not maintain human uterine quiescence during pregnancy.

Authors:  A Barber; S C Robson; F Lyall
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

7.  Lack of effect of carbon monoxide inhibitor on relaxation induced by electrical field stimulation in corpus cavernosum.

Authors:  Y C Kim; M G Davies; L Marson; P O Hagen; C C Carson
Journal:  Urol Res       Date:  1994

8.  Blood pressure and renal blow flow responses in heme oxygenase-2 knockout mice.

Authors:  David E Stec; Trinity Vera; Megan V Storm; Gerald R McLemore; Michael J Ryan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-10-21       Impact factor: 3.619

9.  Role of constitutively expressed heme oxygenase-2 in the regulation of guinea pig coronary artery tone.

Authors:  Hristo Gagov; Boris Kadinov; Kiril Hristov; Kiril Boev; Dimiter Itzev; Thomas Bolton; Dessislava Duridanova
Journal:  Pflugers Arch       Date:  2003-05-22       Impact factor: 3.657

10.  Carbon monoxide inhibits L-type Ca2+ channels via redox modulation of key cysteine residues by mitochondrial reactive oxygen species.

Authors:  Jason L Scragg; Mark L Dallas; Jenny A Wilkinson; Gyula Varadi; Chris Peers
Journal:  J Biol Chem       Date:  2008-07-01       Impact factor: 5.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.